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Summary 
Background Noma is a poorly studied disease that leads to severe facial tissue destruction in children in developing 
countries, but the cause remains unknown. We aimed to identify the epidemiological and microbiological risk factors 
associated with noma disease.
Methods We did a prospective, matched, case-control study in Niger between Aug 1, 2001, and Oct 31, 2006, in children 
younger than 12 years to assess risk factors for acute noma. All acute noma cases were included and four controls for 
each case were matched by age and home village. Epidemiological and clinical data were obtained at study inclusion. 
We undertook matched-paired analyses with conditional logistic regression models.
Findings We included 82 cases and 327 controls. Independent risk factors associated with noma were: severe stunting 
(odds ratio [OR] 4·87, 95% CI 2·35–10·09) or wasting (2·45, 1·25–4·83); a high number of previous pregnancies in 
the mother (1·16, 1·04–1·31); the presence of respiratory disease, diarrhoea, or fever in the past 3 months 
(2·70, 1·35–5·40); and the absence of chickens at home (1·90, 0·93–3·88). After inclusion of microbiological data, 
a reduced proportion of Fusobacterium (4·63, 1·61–13·35), Capnocytophaga (3·69, 1·48–9·17), Neisseria 
(3·24, 1·10–9·55), and Spirochaeta in the mouth (7·77, 2·12–28·42), and an increased proportion of Prevotella 
(2·53, 1·07–5·98), were associated with noma. We identiﬁ ed no speciﬁ c single bacterial or viral pathogen in cases.
Interpretation Noma is associated with indicators of severe poverty and altered oral microbiota. The predominance 
of speciﬁ c bacterial commensals is indicative of a modiﬁ cation of the oral microbiota associated with reduced 
bacterial diversity. 
Funding Gertrude Hirzel Foundation.
Introduction
Noma is a gangrenous disease causing high mortality and 
devastating facial lesions with severe functional and 
aesthetic consequences.1 Hippocrates ﬁ rst described noma 
in the 5th century BC2 and the disease continued to be 
reported throughout Europe until World War 2, when the 
last reports of noma concerned concentration camp and 
prison camp inmates.3,4 In high-income countries, noma is 
now extremely rare and aﬀ ects only patients with severe 
immunosuppression or blood dyscrasia.5–8 By contrast, 
noma still persists in the poorest developing countries—
mostly in Africa—and occurs mainly in children younger 
than 6 years. Cases have also been reported from Latin 
America and the Asia-Paciﬁ c region.9,10 Although noma 
cannot be regarded as a major public health problem 
worldwide, the facial mutilations caused by the disease are 
intolerable and further research is needed to alleviate the 
suﬀ ering of aﬀ ected underprivileged populations.
Noma disease develops from a gingival lesion that 
spreads to the underlying bone. The corresponding facial 
region develops oedema and becomes necrotic, leading to 
the destruction of large parts of the soft and hard facial 
tissues.1 Findings from observational studies have 
suggested several possible risk factors for noma disease, 
including poverty,11 stunting owing to malnutrition,12 low 
birthweight,13 absence of exclusive breastfeeding, poor 
sanitation, endemic infections (measles, malaria, and 
AIDS), poor oral hygiene, and proximity of livestock.11–13 
Although these factors might have a role in a cascade of 
events leading to a catastrophic derailment of a disorder 
that is essentially an opportunistic infection associated 
with poor health status, the cause of noma remains largely 
unknown.1,11 We aimed to identify risk factors for noma, 
including epidemiological, biological, microbiological, 
and sociobehavioural variables. 
Methods
Study design and participants
We did a prospective, matched, case-control study of all 
children diagnosed with acute noma between Aug 1, 
2001, and Oct 31, 2006, in the Zinder region of southeast 
Niger, a landlocked country in western Africa. 
Cases were children younger than 12 years who 
presented with acute necrotising stomatitis with 
exposure of underlying bone, oedema, or initial facial 
necrosis (ﬁ gures 1A and B).1 Controls were children 
without any signs of noma or acute necrotising gingivitis 
at study inclusion and matched for age (within 
3 months) and home village to cases recruited within 
1 month of noma diagnosis. Children with sequelae 
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from a previous episode of noma were excluded 
(ﬁ gures 1C and D). 
The study was done in accordance with the Declaration 
of Helsinki and in collaboration with Sentinelles, a 
Swiss non-governmental humanitarian organisation. 
Signed consent (usually by a cross or a ﬁ ngerprint) by 
the parent or guardian of the child was obtained after 
oral information was given by local staﬀ  in the native 
language and translated from a French information 
leaﬂ et. All consent forms were sent to the oﬃ  ce of the 
Geneva Study Group on Noma (GESNOMA) in Geneva, 
Switzerland. The study was approved by the Ministry of 
Health of Niger and the WHO noma programme.
Clinical and biological data collection
We did structured interviews with the child’s family 
members at the time of diagnosis for children with noma 
and at study inclusion for controls, followed by a clinical 
examination. We recorded demographic, clinical, and 
nutritional data, including environmental variables, and 
documented the presence and extent of facial and oral 
lesions.14 We did viral sampling by gently rolling a cotton 
swab tip around the mouth mucosal surface; samples 
were then stored in dedicated tubes for virus shipment. 
Microbial samples were taken from the subgingival 
plaque of teeth with paper points and immersed 
immediately in guanidinium thiocyanate buﬀ er 
(RLT-Buﬀ er, Qiagen, Basel, Switzerland). In noma 
patients, one sample was taken from a diseased site and 
one from a healthy dentition site. In children presenting 
with substantial destruction of the gingival tissue with no 
existing gingival sulcus, the sample was collected at the 
edge of the lesion. For controls, only one sample was 
taken from a mandibular anterior tooth. 
We took blood samples from both groups. All aliquots 
of plasma, gingival ﬂ uid, and mucosal swabs were stored 
at –20°C until shipment and stored on delivery at –80°C 
at University of Geneva Hospitals. We assessed present 
(wasting) and past (stunting) nutritional status by 
anthropometric indicator estimates proposed by WHO 
and the US Centers for Diseases Control and Prevention 
(CDC).15 Scores obtained were calculated and compared 
with the standard values of the US National Center for 
Health Statistics. 
Biological analyses
We measured plasma concentrations of retinol 
(vitamin A) and α-tocopherol (vitamin E) with 
high-performance liquid chromatography (Beckman 
System Gold, 166 Detector, Beckman Instruments, 
Fullerton, CA, USA) according to standard techniques.16 
Serology for Epstein–Barr virus used indirect 
immunoﬂ uorescence assay and quantitative determination 
of IgM and IgG antibodies against viral capsid antigen in 
human serum (Abbott AG, Baar/Zug, Switzerland). For 
herpes simplex virus, varicella zoster virus, 
cytomegalovirus, and morbillivirus (measles), we used 
speciﬁ c enzyme immunoassays (Siemens, Marburg, 
Germany) for the qualitative detection and the quantitative 
determination of IgM and IgG antibodies. Immunity to 
measles was deﬁ ned as a positive IgG serology, a record 
of putative measles vaccination, or a history of disease 
when serology results were unavailable. Mucosal swabs 
were inoculated on human ﬁ broblasts (primary culture 
strains) and three continuous cell lines (A549, Vero, and 
MDCK) to detect the possible presence of viruses. In a 
second step, cytomegalovirus early antigen from saliva 
and mucosal swabs was assessed with shell vial cell 
culture technique and by staining with monoclonal 
antibodies (Argene, Varilhes, France).
Microbiological procedures and microarrays
We extracted total genomic DNA with glass beads 
(diameter 212–300 μm; Sigma-Aldrich, Buchs, Switzerland) 
and a DNeasy kit (Qiagen), according to the manufacturer’s 
instructions. We undertook asymmetrical PCR with 
biotinylated universal primers fD1 (0·4 μM) and rD1 
(4 μM) as described previously.17 We used spectrophotometry 
(NanoDrop ND-1000 Spectrophotometer, NanoDrop 
Figure 2: Noma epidemic curve between Aug 1, 2001, and Oct 31, 2006, in the Zinder region of Niger 
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Figure 1: Examples of noma lesions
(A) A 3-year-old-girl with acute noma, showing oedema and necrosis. (B) A 3-year-old boy with acute noma, 
showing necrosis and important loss of tissue. (C and D) Children with more advanced noma stages showing a 
well-deﬁ ned loss of substance. 
A B C D
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Technologies Wilmington, DE, USA) for quality control 
and quantiﬁ cation of PCR products.
On the basis of the most relevant sequences identiﬁ ed in 
a previous pilot investigation,18 we designed a low-density 
16S rDNA array. Brieﬂ y, from a dataset containing 
1237 partial 16S rRNA gene sequences representing 
339 diﬀ erent phylotypes, we scanned 132 sequences 
showing an abundance of at least 1% for probes respecting 
deﬁ ned physicochemical properties (Huyghe A, et al, 
University of Geneva, personal communication), leading 
Figure 3: Geographical localisation of the study population, Zinder region, Niger, Africa
(A) Niger (capital: Niamey) and surrounding African countries. (B) Geographical distribution of noma cases between Aug 1, 2001, and Oct 31, 2006, in the Zinder 
region of Niger
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to a set of 271 probes. Additionally, we included probes 
speciﬁ c to various Archaebacteria and eight negative 
control probes, resulting in a ﬁ nal set of 335 probes. 
Oligonucleotide probes were synthesised with a C6-linker 
with free primary amine and spotted on ArrayStrip 
microarrays (Clondiag GmbH, Jena, Germany). We 
processed microarrays with proprietary reagents according 
to the manufacturer’s instructions. We established signal 
intensities with IconoClust software (Clondiag GmbH). 
For every spot, the extinction signal of local background 
was subtracted from the intensity value. Array signals were 
ﬁ rst adjusted to normalise the DNA quantity. Each array 
was then normalised against the eight negative control 
probes and subjected to quantile normalisation with the 
Partek Genomic Suite 6.4. 
Statistical analysis
The sample size was calculated to detect a 2·5-fold 
increase in the odds of development of noma in the 
presence of one speciﬁ c predictor with 5% signiﬁ cance 
and 80% power. The calculation showed that 80 cases, 
each with four matched controls, would be necessary to 
show such an association.19 We assumed that the main 
risk factor would be present in 60% of controls and that 
the correlation coeﬃ  cient for exposure between matched 
cases and controls would be 0·45. 
To assess independent risk factors, we included all 
variables associated with an increased likelihood of noma 
in univariate analysis at a signiﬁ cance level of a p=0·25 
in a multivariate, conditional logistic regression model 
with a forward stepwise procedure. We estimated the 
percentage of variance in the outcome explained by the 
model by calculation of a pseudo-R² value.
Microarray data were also analysed by conditional 
logistic regression. We compared diseased with healthy 
sites in cases, healthy sites in cases with controls, and 
diseased sites in cases with controls. We corrected for 
multiple testing with the false discovery rate method;20 all 
p values less than 0·0238 were regarded as signiﬁ cant. 
The 132 phylotypes with signiﬁ cant p values led to 
396 conditional logistic regression models. Bacterial 
genera that were signiﬁ cantly associated with case-control 
status at conditional logistic regression were analysed and 
tested for log linearity. Since log linearity was not respected, 
we used categorical variables, based on the quintiles of 
their distribution for each bacteria. Variables retained in 
the two previous steps were included in the ﬁ nal 
conditional logistic regression model. Because of the low 
number of events per variable,21 we presented a 
parsimonious model including only signiﬁ cant variables 
associated with the case status plus age that was kept in 
the model. All clinical and epidemiological variables and 
microbiological data from the healthy site of noma cases 
signiﬁ cantly associated with noma status were kept in the 
ﬁ nal model. All tests were two-tailed and p values less than 
0·05 were regarded as signiﬁ cant. We used Stata 
(version intercooled 12.0) for all analyses. 
Cases 
(n=82) 
Controls 
(n=327) 
p value*
Sociodemographic variables
Age at study entry (years) 3·7 (1·7) 4·0 (1·6) 0·002
Female sex 41 (51·9%) 160 (48·9%) 0·63
Mother’s age (years) 0·36
<20 7 (8·6%) 46 (14·1%) ··
21–25 20 (24·7%) 87 (26·6%) ··
26–30 24 (29·6%) 95 (29·1%) ··
>30 31 (37·8%) 99 (30·3%) ··
Father’s profession 0·42
Farmer 43 (53·1%) 192 (58·7%) ··
Storekeeper 20 (24·7%) 69 (21·1%) ··
Other 19 (23·2%) 66 (20·2%) ··
Number of people living in the household 7·3 (3·1) 6·2 (2·5) 0·001
Number of children per mother 5·3 (2·4) 4·3 (2·5) 0·001
Sibling chronological order 0·02
First position 8 (9·8%) 78 (23·8%) ··
Second position 15 (18·3%) 73 (22·3%) ··
Third position 15 (18·3%) 48 (14·7%) ··
Fourth–ﬁ fth position 19 (23·2%) 65 (19·9%) ··
>Fifth position 25 (30·4%) 63 (19·3%) ··
Clinical variables
History of malaria 0·00026†
No 3 (3·7%) 45 (13·8%) ··
Yes (>3 months before) 79 (96·3%) 282 (86·2%) ··
Yes (in the past 3 months) 33 (43·4%) 76 (23·2%) ··
Natural immunity or vaccination against measles 0·08
No 52 (63·4%) 235 (71·9%) ··
Yes 30 (36·6%) 92 (28·1%) ··
History of measles in the past 6 months 0·81
No 80 (97·6%) 320 (97·9%) ··
Yes 2 (2·4%) 7 (2·1%) ··
Fever, respiratory disease, or diarrhoea in the past 3 months <0·0001
No 38 (46·3%) 216 (66·1%) ··
Yes 44 (53·7%) 111 (33·9%) ··
Nutritional status
Mid-upper-arm circumference (cm)* 12·9 (2·7) 15·1 (4·9) <0·0001
Height-for-age Z score –2·5 (1·8) –0·9 (1·8) <0·0001
Categories of height-for-age Z score <0·0001
No stunting 29 (37·2%) 236 (72·2%) ··
Moderate stunting (between –3 SD and –2 SD) 19 (24·4%) 49 (15·0%) <0·0001
Severe stunting (less than –3 SD) 30 (38·5%) 42 (12·8%) <0·0001
Weight-for-age Z score –5·2 (3·5) –2·7 (1·9) <0·0001
Weight-for-height Z score –4·3 (3·2) –3·5 (2·9) <0·0005
Categories of weight-for-height Z score <0·0001
No wasting 34 (41·5%) 151 (46·2%) ··
Moderate wasting (between –3 SD and –2 SD) 14 (17·1%) 101 (30·9%) 0·61
Severe wasting (less than –3 SD) 34 (41·5%) 75 (22·9%) 0·001
Data are mean (SD) or number (%). *Provided by conditional logistic regression. †Comparison between history of 
malaria in the past 3 months and no crisis or malaria more than 3 months before noma. 
Table  1: Sociodemographic and clinical characteristics of children with noma compared with controls 
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Role of the funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication. 
Results
We recruited 85 noma cases and 327 controls. Three cases 
were excluded for administrative reasons, resulting in 
82 eligible cases. For one case, only three controls were 
matched. Overall, seven deaths (8·5%) were attributable 
to noma; one other child died 1 year after noma diagnosis 
because of malaria complications. All children received 
adequate antibiotics (amoxicillin plus metronidazole) 
immediately after diagnosis and biological specimen 
sampling. Figure 2 shows the epidemic curve of new 
noma cases during the study period. Cases were 
identiﬁ ed from all areas of the Zinder region (ﬁ gure 3).
Table 1 shows the baseline characteristics of the study 
population. Most cases were recruited at the Sentinelles 
centre for noma care after referral from a dispensary 
(n=28, 34·1%) or a hospital (n=22, 26·8%), or were 
brought in by their family (n=26, 31·7%). Six (7·3%) cases 
were identiﬁ ed in remote villages during follow-up visits 
to children who had previously been operated on. Mean 
delay to consultation at the centre was 8·1 days (SD 12·6; 
median 3 days, range 0–50). 20 patients (24·4%) had 
already received antibiotics for more than 24 h, and 
Cases 
(n=82)
Controls 
(n=327)
p value*
Nutritional habits
Breastfeeding duration 
(months)
20·2 (2·6) 20·7 (2·4) 0·01
Children still breastfed 0·34
Yes 3 (3·7%) 7 (2·1%) ··
No 79 (96·3%) 320 (97·9%) ··
Daily consumption of millet 82 (100·0%) 327 (100·0%) 0·99
Daily consumption of 
sorghum
80 (97·6%) 324 (99·1%) 0·21
Daily consumption of rice 79 (96·3%) 323 (98·8%) 0·99
Daily consumption of beans 79 (96·3%) 327 (100·0%) 0·99
Daily consumption of milk 
(animal origin)
16 (19·5%) 94 (28·8%) 0·04
Meat consumption 0·38
Daily† 9 (11·1%) 29 (8·9%) ··
Weekly 52 (64·2%) 227 (69·9%) 0·45
Monthly 20 (24·7%) 69 (21·2%) 0·76
Fish consumption 0·02
Daily or weekly† 33 (40·3%) 102 (31·3%) ··
Monthly 24 (29·3%) 140 (42·9%) 0·01
Never 25 (30·5%) 84 (25·8%) 0·63
Fruit consumption 0·35
Daily† 13 (16·5%) 46 (14·3%) ··
Weekly 49 (62·0%) 214 (66·7%) 0·50
Monthly 17 (21·5%) 61 (19·0%) 0·73
Vegetable consumption 0·37
Daily† 16 (20·0%) 62 (19·2%) ··
Weekly 54 (67·5%) 201 (62·2%) 0·84
Monthly 10 (12·5%) 60 (18·6%) 0·27
Recent nutritional habits (within the past month)
Number of meals per day 3·72 (0·58) 3·52 (0·52) 0·004
Number of meals per day 
within the past month 
2·57 (0·89) 3·50 (0·56) <0·0001
Direct contact with animals
Donkey 0·89
Yes 16 (19·5%) 62 (19·0%) ··
No 66 (80·5%) 264 (81·0%) ··
Goat 0·84
Yes 63 (76·8%) 247 (75·8%) ··
No 19 (23·2%) 79 (24·2%) ··
Cow 0·45
Yes 27 (32·9%) 118 (36·2%) ··
No 55 (67·1%) 208 (63·8%) ··
Sheep 0·04
Yes 26 (31·7%) 139 (42·6%) ··
No 56 (68·3%) 187 (57·4%) ··
Horse 0·15
Yes 8 (9·8%) 45 (13·8%) ··
No 74 (90·2%) 281 (86·2%) ··
Dog 0·48
Yes 2 (2·4%) 11 (3·4%) ··
No 80 (97·6%) 315 (96·6%) ··
(Continues in next column)
Cases 
(n=82)
Controls 
(n=327)
p value*
(Continued from previous column)
Cat 0·11
Yes 2 (2·4%) 20 (6·1%) ··
No 80 (97·6%) 306 (93·9%) ··
Chicken 0·005
Yes 27 (32·9%) 154 (47·2%) ··
No 55 (67·1%) 172 (52·8%) ··
Guinea fowl 0·99
Yes 1 (1·2%) 19 (5·8%) ··
No 81 (98·8%) 307 (94·2%) ··
Duck 0·57
Yes 1 (1·2%) 2 (0·6%) ··
No 81 (98·8%) 324 (99·4%) ··
Camel 0·99
Yes 0 (0·0%) 4 (1·2%) ··
No 82 (100·0%) 322 (98·8%) ··
Rat 0·16
Yes 5 (6·1%) 12 (3·7%) ··
No 77 (93·9%) 314 (96·3%) ··
Data are mean (SD) or number (%). *Provided by conditional logistic regression. 
†Denotes reference groups in conditional logistic regression. 
Table 2: Nutritional habits and environmental life conditions of children 
with noma compared with controls
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33 (40·2%) had been exposed to traditional medicine 
procedures before seeking medical attention. 
At clinical presentation, 24 cases (29·3%) had a body 
temperature of 38·5°C or higher, 73 (89·0%) enlarged 
submandibular lymph nodes, six (7·3%) general oedema, 
and ﬁ ve (6·1%) ascites. Locally, cases presented with facial 
oedema (n=45, 54·9%) or initial necrosis (n=38, 46·3%), 
with external (n=22, 26·8%) or buccal (n=68, 82·9%) bone 
exposure, or both. 75 cases (91·5%) had local pain. At oral 
assessment, 77 cases (93·9%) presented with halitosis and 
61 (75·4%)  with pseudomembranes. 68 (82·9%) showed 
signs of gingivitis, including 45 (54·9%)  with spontaneous 
gingival bleeding. 60 cases (73·1%)  showed loss of tips of 
interdental gingival papilla and 35 (42·7%)  presented 
with other oral lesions. Table 2 shows a comparison of the 
nutritional habits and environmental life conditions 
between cases and controls. 
Because of poor health conditions and dehydration, 
blood samples from only 20 cases (24·4%) and 
114 controls (34·9%) were available for measurement of 
vitamin concentrations (table 3). We recorded very low 
serum concentrations of vitamins A and E (<1 μmol/L) in 
both groups. Antiviral antibody concentrations for 
diﬀ erent viruses could be measured in samples 
for 61–69 cases (74·4–84·1%) and 239–317 controls 
(73·1–96·9%; table 3). We recorded no signiﬁ cant 
diﬀ erence between cases and controls in terms of recent 
or past immunisation against measles (IgG positivity 
<65% in both groups) or other viral diseases (table 3). 
Mucosal swab testing did not identify notable acute viral 
illness in cases or controls (table 3).
On the basis of complete clinical epidemiological data 
available for 407 children (table 4), severe wasting and 
stunting, a high number of past pregnancies in the 
mother, the presence of febrile illness in the past 
3 months, and the absence of chickens at home were 
signiﬁ cant risk factors for noma disease. The proportion 
of variance explained by the model was 27%. 
After exclusion of 20 cases who received antibiotics or 
whose specimens deteriorated, we processed 117 microbial 
samples from noma cases (59 from diseased sites and 
58 from healthy sites) and 235 from controls. Each 
specimen yielded a maximum of 132 diﬀ erent results 
corresponding to the number of phylotypes sought by 
low-density 16s rDNA array.22 Of 396 comparisons, 
185 (46·7%) provided signiﬁ cant diﬀ erences with use of 
the predetermined false discovery rate cutoﬀ . We used 
data from the healthy sites of cases and obtained complete 
data for 291 observations (59 cases and 232 controls), 
which were similar in all characteristics to the original 
dataset of 409 children (82 cases and 327 controls; data 
not shown). By multivariate analysis, we identiﬁ ed ﬁ ve 
bacterial genera that were signiﬁ cantly associated with 
case status compared with controls: Capnocytophaga, 
Fusobacterium, Neisseria, Prevotella, and Spirochaeta 
(table 5). When we introduced microbiological variables 
into the clinicoepidemiological model (table 6), severe 
stunting and a higher number of past pregnancies in the 
mother were independently associated with noma, 
together with microbiological predictors of disease: a 
reduced proportion of Spirochaeta, Fusobacterium, 
Capnocytophaga, and Neisseria in the oral microbiota, but 
an increased proportion of Prevotella. The proportion of 
variance explained by the model was 42%.
Cases Controls  p value*
Viral serology n=61–69 n=239–317
Serology for cytomegalovirus, IgM 0·53
Positive 17/61 (27·9%) 50/239 (20·9%) ··
Negative 44/61 (72·1%) 189/239 (79·1%) ··
Serology for cytomegalovirus, IgG 0·91
Positive 60/61 (98·4%) 246/250 (98·4%) ··
Negative 1/61 (1·6%) 4/250 (1·6%) ··
Serology for Epstein–Barr virus, IgM 0·74
Positive 4/62 (6·6%) 12/266 (4·5%) ··
Negative 58/62 (93·6%) 254/266 (95·5%) ··
Serology for Epstein–Barr virus, IgG 0·11
Positive 58/63 (92·1%) 263/276 (95·3%) ··
Negative 5/63 (7·9%) 13/276 (4·7%) ··
Serology for herpes simplex virus, IgM 0·54
Positive 1/62 (1·6%) 3/317 (1·0%) ··
Negative 61/62 (98·4%) 314/317 (99·0%) ··
Serology for herpes simplex virus, IgG 0·93
Positive 54/69 (81·8%) 229/292 (78·5%) ··
Negative 12/69 (18·8%) 63/292 (21·5%) ··
Serology for varicella zoster virus, IgM 0·97
Positive 2/65 (3·1%) 8/283 (2·8%) ··
Negative 63/65 (96·9%) 275/283 (97·2%) ··
Serology for varicella zoster virus, IgG 0·60
Positive 7/62 (11·3%) 39/278 (14·0%) ··
Negative 55/62 (88·7%) 239/278 (86·0%) ··
Serology for measles, IgM 0·23
Positive 3/61 (4·9%) 5/288 (1·7%) ··
Negative 58/61 (95·1%) 283/288 (98·3%) ··
Serology for measles, IgG 0·19
Positive 39/62 (62·9%) 145/252 (57·5%) ··
Negative 23/62 (37·1%) 107/252 (42·5%) ··
Mucosal swabs n=78 n=265
Cytomegalovirus PCR 0·99/0·99
Oral presence of cytomegalovirus (healthy:lesion 
side)
1:0 0 ··
Absence of oral presence of cytomegalovirus 
(healthy:lesion side)
78:77 265 ··
Other viruses PCR 0·99/0·19
Oral presence (healthy:lesion side) 0:3† 2‡ ··
Absence of oral presence (healthy:lesion side) 77:75 261 ··
Vitamins n=20 n=114
Vitamin A concentration (μmol/L) 0·82 (0·53) 0·51 (0·38) 0·005
Vitamin E concentration (μmol/L) 0·80 (2·57) 0·41 (1·71) 0·50
Data are n/N (%) or mean (SD) unless otherwise indicated. *Provided by conditional logistic regression. †Adenovirus 
(n=1), herpes simplex virus 1 (n=1), and Coxsackie virus (n=1). ‡Herpes simplex virus 1 (n=1) and poliovirus 1 (n=1). 
Table 3: Biological and viral variables in children with noma compared with controls
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Discussion
Our ﬁ ndings provide new insight into the understanding 
of the risk factors for noma disease and take into account 
sociodemographic, clinical, biological, and microbiological 
factors that are potentially involved in its pathogenesis 
(panel).1,11,23 Disease predictors include severe 
malnutrition, recent respiratory or diarrhoeal syndrome, 
the number of previous pregnancies in the mother, the 
absence of chickens at home, and an altered oral 
microbiota compared with controls.
Malnutrition was very apparent in our study population. 
Importantly, both present and past malnutrition was a 
risk factor for noma.24 By comparing each case to four 
matched controls, we showed that aﬀ ected children were 
more undernourished than were controls. In Niger, 
chickens are a sign of wealth and their absence in the 
case environment and the presence of a higher number 
of people in the household are surrogate indicators of 
poverty that might explain the degree of acute and 
chronic malnutrition of these children. Investigators of 
some studies13,25 have reported that noma could be related 
to a higher number of previous pregnancies in the 
mother. In sub-Saharan Africa, pregnant and lactating 
women are especially at risk of maternal malnutrition 
related to poor nutritional quality and short 
interpregnancy intervals.26 Frequent pregnancies often 
cause maternal anaemia, resulting in an increased risk 
of low-birthweight babies.11,13
Debilitating diseases, especially malaria and measles, 
have been described as possible contributory factors for 
noma.4,24 We noted that the risk of noma increased in the 
presence of a recent febrile respiratory or digestive illness, 
which again suggests that aﬀ ected children had a worse 
health status than did controls. Measles could be one of the 
most important risk factors for noma because of the 
accompanying immunosuppression.24,25 Our data showed 
that immunity against measles, either through vaccination 
or previous disease, was insuﬃ  cient in the overall study 
population, and exposure to measles was not associated 
with an increased risk of disease. Herpes viruses, 
particularly cytomegalovirus or Epstein-Barr virus, could 
trigger the evolution of a pre-existing gingivitis towards 
acute necrotising gingivitis and noma.11,12,27 Although we 
tested for the presence of herpes in mucosal swabs, our 
results seemed to exclude this hypothesis, but we could 
not exclude a type 2 error or the existence of a viral pathway 
that we did not explore in our study. 
In addition to the many epidemiological facets of the 
disease, noma has always been regarded as a disease of 
bacterial origin because of the smell of the lesion, its 
rapid evolution, and possible response to broad-spectrum 
antibiotic treatment.1,11,12,28 Apart from ﬁ ndings from 
early studies29,30 that reported the presence of 
spirochaetes and fusiform organisms via dark ﬁ eld 
microscopy, recent eﬀ orts to prove a primary 
microbiological cause have been unsuccessful because 
of diﬃ  culties in accessing and assessing acute cases31 
and the unavailability of modern laboratory techniques 
in the countries where noma is present. Microbiota 
associated with noma lesions were studied in a few 
patients with anaerobic culturing techniques.32 
Microorganisms identiﬁ ed as Fusobacterium 
necrophorum and Prevotella intermedia on the basis of 
phenotypic criteria were recovered from seven and six 
of the eight sampled noma lesions, respectively. In our 
study, we used advanced molecular techniques and 
included only acute noma cases to investigate potential 
causative microorganisms. Microarrays oﬀ er the dual 
advantage of assessment of the possible presence of a 
Univariate model Multivariate model*
Odds ratio 
(95% CI)
p value Odds ratio 
(95% CI)
p value
Severe stunting (HAZ<–3 SD) 5·22 
(2·73–9·97)
<0·0001 4·87 
(2·35–10·09)
<0·0001
Severe wasting (WHZ<–3 SD) 3·01 
(1·66–5·43)
0·00027 2·45 
(1·25–4·83)
0·009
Number of mother’s past pregnancies 1·19 
(1·08–1·32)
0·0005 1·16 
(1·04–1·31)
0·01
Respiratory disease, diarrhoea, or fever in the past 
3 months
3·52 
(1·89–6·54)
<0·0001 2·70 
(1·35–5·40)
0·005
Absence of chickens at home 2·53 
(1·32–4·82)
0·005 1·90 
(0·93–3·88)
0·08
Age at diagnosis (years) 0·46 
(0·29–0·72)
0·001 0·54 
(0·34–0·87)
0·01
HAZ=height-for-age Z score. WHZ=weight-for-height Z score. *Odds ratio from a multivariate conditional logistic 
regression model (n=407). The pseudo-R2 of the multivariate model was 0·27. 
Table 4: Risk factors for noma disease identiﬁ ed in children included in the study (univariate and 
multivariate models without microbiological data)
Odds ratio* (95% CI) p value
Capnocytophaga genus 0·002
≥25th percentile 1·00 ··
<25th percentile 4·02 (1·68–9·64) ··
Fusobacterium genus 0·003
≥75th percentile 1·00 ··
<75th percentile 4·52 (1·69–12·10) ··
Neisseria genus 0·005
≥75th percentile 1·00 ··
<75th percentile 4·50 (1·57–12·89) ··
Prevotella genus 0·007
<50th percentile 1·00 ··
≥50th percentile 3·15 (1·37–7·20) ··
Spirochaeta genus <0·000385
≥75th percentile 1·00 ··
<75th percentile 10·61 (2·88–39·07) ··
Percentiles refer to the quantile of distribution of the signal obtained from the 
microarrays, which provide the relative quantity of each speciﬁ c genus in the 
sample tested. *Odds ratio from a multivariate conditional logistic regression 
model (n=291). The pseudo-R2 of the model was 0·35. 
Table 5: Bacterial genera associated with noma in children enrolled in 
the study
Articles
e94 www.thelancet.com/lancetgh   Vol 1   August 2013
large panel of phylotypes and quantiﬁ cation of their 
relative proportion in the subgingival microbiota. Until 
now, conventional microbiological techniques could 
have led to an underestimation of the amount of 
microbiological diversity. 
We noted signiﬁ cant independent associations 
between noma and microbiological species, including a 
trend towards an increased risk of disease when the 
Fusobacterium genus was under-represented. 
F necrophorum, a commensal found in the gut of 
herbivores and a cause of necrotising infections in 
animals, might contaminate livestock and potentially 
infect children.11,32 F necrophorum was found in seven of 
eight advanced noma lesions in a previous report31 and 
has long been regarded as one of the putative pathogens 
of noma.31,32 However, the ten phylotypes of Fusobacterium 
genus recorded in our study belong to the Fusobacterium 
nucleatum complex (data not shown). Other 
representatives of the Fusobacteriales family tended to 
be associated with healthy sites. Thus, the intriguing 
hypothesis that F necrophorum could act as a trigger 
organism was not conﬁ rmed in our study with 
molecular techniques. Rather, we noted an alteration of 
the oral microbiota of noma cases, with a reduced 
amount of Fusobacterium genus. By contrast, 
P intermedia, a pathogen identiﬁ ed frequently in adult 
periodontitis,32 was clearly associated with noma. In 
previous studies, investigators have reported its 
presence and its putative role in noma lesions;11,32,33 it 
might play a part by promoting tissue destruction 
through lipid and protein degradation.31 P intermedia 
produces IgA1 proteases that could be crucial in 
changing mouth mucosal immunity,34,35 but this species 
is not recognised as a mono-infecting agent.36,37 Noma 
cases also had a lower proportion of Capnocytophaga spp, 
Neisseria spp, and Spirochaeta spp than did controls. In a 
study in which investigators compared the microbial 
composition of supragingival and subgingival plaque of 
patients with periodontitis, supragingival samples had 
statistically signiﬁ cantly higher counts of 
Neisseria mucosa, Capnocytophaga ochracea, and 
Capnocytophaga sputigena than did the subgingival 
samples, whereas subgingival samples, taken from the 
same teeth, had statistically signiﬁ cantly higher counts 
of Prevotella nigrescens and P intermedia than did 
supragingival samples.38 This diﬀ erence might 
represent an imbalance in the microbiota, with a 
composition more closely related to the subgingival 
microbiota in periodontal diseases that promotes the 
overgrowth of opportunistic pathogens. Importantly, we 
did not identify any speciﬁ c causative pathogen for 
noma disease with low-density microarrays. However, 
for technical reasons and density issues, the microarray 
analysis is dedicated only to bacteria and some Archaea, 
but did not detect fungi or parasites. Of note, neither 
fungi nor parasites have been suspected in the 
pathogenesis of noma disease.1,11 
Our study has some limitations. First, we did not 
strictly respect age matching between cases and 
controls (ie, we attempted to match controls to their 
cases in terms of age, but globally we found that 
matched controls were signiﬁ cantly older than cases) 
Univariate model Multivariate model*
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Severe stunting (HAZ< –3 SD) 6·28 (2·79–14·15) <0·0001 2·86 (1·05–7·76) 0·04
Number of mother’s past pregnancies 1·18 (1·05–1·33) 0·004 1·21 (1·04–1·40) 0·01
Age at diagnosis (years) 0·41 (0·23–0·71) 0·002 0·72 (0·38–1·37) 0·317
Capnocytophaga genus
<25th percentile (vs ≥25th percentile) 6·42 (3·19–12·92) <0·0001 3·69 (1·48–9·17) 0·005
Fusobacterium genus
<75th percentile (vs ≥75th percentile) 1·97 (0·91–4·27) 0·084 4·63 (1·61–13·35) 0·005
Prevotella genus
≥50th percentile (vs <50th percentile) 3·35 (1·78–6·27) 0·000169 2·53 (1·07–5·98) 0·035
Neisseria genus
<75th percentile (vs ≥75th percentile) 5·55 (2·54–12·13) <0·0001 3·24 (1·10–9·55) 0·033
Spirochaeta genus
<75th percentile (vs ≥75th percentile) 3·20 (1·20–8·54) 0·02 7·77 (2·12–28·42) 0·002
HAZ=height-for-age Z score. *Odds ratio from a multivariate conditional logistic regression model (n=291). Age was 
kept in the model (even if non-signiﬁ cant). The pseudo-R2 of the multivariate model was 0·42. 
Table 6: Risk factors for noma disease identiﬁ ed in children included in the study (univariate and 
multivariate models including microbiological data)
Panel: Research in context
Systematic review
We searched PubMed and Medline for papers published in French and English between 
Jan 1, 1969 and Oct 1, 2012, with the terms “noma”, “cancrum oris”, “acute necrotizing 
gingivitis/acute necrotizing ulcerative gingivitis and noma”, “acute necrotizing gingivitis/
acute necrotizing ulcerative gingivitis and malnutrition”, “acute necrotizing gingivitis/
acute necrotizing ulcerative gingivitis and herpes viruses/herpesviridae”, and 
“Fusobacterium necrophorum”. We also searched the reference lists of identiﬁ ed articles 
for further relevant papers and the personal libraries of the authors (DB-M, BP-C, AM, DM, 
JS, and DP). Previous studies of risk factors for noma reported the importance of 
malnutrition and debilitating diseases, such as malaria or measles. However, no 
investigators have done a case-control study that includes only acute cases and control 
children from the same region and at the same time. Moreover, none of the previous 
studies presented a formal sample size estimation, which suggests that these studies 
might have had inadequate power to detect a speciﬁ c association with some bacteria or 
other risk factors. Of note, early studies suggested that bacteria had a crucial role in noma 
pathogenesis, but most had a small sample size and included patients with non-acute 
noma. Finally, previous analyses used only microscopy and culture techniques that were 
standard at the time of the study.
Interpretation
To the best of our knowledge, this study is the ﬁ rst to assess both epidemiological risk 
factors and microbiology with a case-control design. From a practical perspective, our 
data conﬁ rm the importance of pre-existing malnutrition and the role of poverty in 
children with noma. Our results showed no involvement of speciﬁ c bacteria in the cause 
of the disease. Overall, these data suggest new areas of research and draw attention to 
potential new primary preventive strategies to be developed for the disease.
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but we adjusted for this problem in all multivariate 
models. Second, we attempted blood and other 
biological sampling only once, but it was impossible in 
some cases because of children’s poor health status and 
a high occurrence of dehydration. We excluded 28% of 
observations in the global model because of missing 
data for microbiological variables. However, a 
comparison of the total study population with the 
subset of 291 children without any missing data showed 
that they shared similar characteristics (data not 
shown), which strongly suggests the absence of 
selection bias. Third, the inherent bias common to all 
case-control studies (mainly recall bias, retrospective 
design, and temporality, because risk factors were 
assessed after the development of noma) is certainly 
present in our study, especially in the assessment of 
nutritional habits and environmental life factors. 
However, noma is a rare disease and the case-control 
approach used was the most appropriate design to 
study such a disorder.
We are conﬁ dent that these ﬁ ndings could be 
extrapolated to a larger population of children in Niger 
and surrounding countries. In terms of 
sociodemographic and clinical characteristics, our study 
population was representative of children with noma in 
sub-Saharan Africa. Cases were managed according to 
WHO recommendations, thus making our ﬁ ndings 
gener alisable to the overall at-risk population. 
This study does not provide evidence for the existence 
of one bacterial pathogen as a cause for the disease, 
including previous suspects, but the results do strongly 
suggest that an altered oral microbiota increases the risk 
of disease, independent of sociodemographic and 
environmental factors. Our ﬁ ndings show that the 
eradication of noma disease needs concerted eﬀ orts to 
alleviate poverty, promote improved nutrition of both 
pregnant women and infants, and help to teach parents 
to recognise early signs of the disease. The 2012 report 
on the progress of the UN Millennium Development 
Goals emphasises that the target of reducing extreme 
poverty has been reached 5 years ahead of the 2015 
deadline in Niger.39 Despite this achievement, an urgent 
need remains to associate health campaigns aimed at 
improving oral care with existing successful strategies 
against malnutrition in sub-Saharan countries where 
noma is especially prevalent.1,9,11 
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